Declining renal function after myocardial infarction predicts poorer long-term outcome

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 17, Issue 2, 2010, Pages 181-186

  Aengus Murphy, C ^a   Robb, Stephen D ^a   Weir, Robin A P ^a   McDonagh, Theresa A ^b   Dargie, Henry J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Myocardial infarction; Prognosis; Renal function

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCREENING; SYSTOLIC DYSFUNCTION;

EID: 77951277255     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e328332d48b     Document Type: Article

References (19)

1. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56:2214-2219.
2. Meisinger C, Doring A, Lowel H, KORA Study G. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006; 27:1245-1250.
3. Khan NA, Ma I, Thompson CR, Humphries K, Salem DN, Sarnak MJ, et al. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol 2006; 17:244-253.
4. Perticone F, Sciacqua A, Maio R, Perticone M, Laino I, Bruni R, et al. Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women. Eur J Cardiovasc Prev Rehabil 2009 [Epub ahead of print]
5. Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Pinero G, Avezum A, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 2003; 89:1003-1008.
6. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295.
7. Coceani M, Carpeggiani C, L'Abbate A. Comparative prognostic value of glomerular filtration rate estimating formulas in ischaemic heart disease. Eur J Cardiovasc Prev Rehabil 2008; 15:423-427.
8. Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, et al. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Eur J Cardiovasc Prev Rehabil 2007; 14:312-318.
9. Eijkelkamp WB, De Graeff PA, Van Veldhuisen DJ, Van Dokkum RP, Gansevoort RT, De Jong PE, et al. Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study Group. Effect of first myocardial ischemic event on renal function. Am J Cardiol 2007; 100:7-12.
10. Hillege HL, Van Gilst WH, Van Veldhuisen DJ, Navis G, Grobbee DE, De Graeff PA, et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 2003; 24:412-420.
11. Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, et al. In-hospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 2005; 150:330-337.
12. Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 2006; 17:2886-2891.
13. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002; 8:136-141.
14. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 2006; 12:257-262.
15. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 1996; 93:1981-1992.
16. Campbell S, George DK, Robb SD, Spooner R, McDonagh TA, Dargie HJ, et al. The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease. Heart 2003; 89:1023-1026.
17. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts [see comment]. Clin Chem 1992; 38:1933-1953.
18. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.